Sallie Mae (SLM) closed the most recent trading day at $9.54, moving +1.92% from the previous trading session. This change lagged the S&P 500's 4.94% gain on the day. Meanwhile, the Dow gained 4.89%, and the Nasdaq, a tech-heavy index, added 4.95%.
ViiV Healthcare, the joint venture set up a few years ago by Pfizer (NYSE: PFE), GlaxoSmithKline (NYSE: GSK), and the Japanese drugmaker Shionogi, is moving toward having an HIV treatment that can be dosed monthly -- or even less frequently.
After a disastrous Monday, the Dow turned in an over 1,000-point rally today, as Wall Street recouped some of the historical losses suffered in the previous session. It was an incredibly volatile session, with the blue-chip index trading as much as 160 points lower at its ses
In trading on Tuesday, shares of Ryanair Holdings plc (Symbol: RYAAY) crossed above their 200 day moving average of $73.79, changing hands as high as $73.96 per share. Ryanair Holdings plc shares are currently trading up about 8.2% on the day. The chart below shows the one y
Wall Street roared back to life on Tuesday, rebounding from the brink of bear market confirmation as bargain-hunting and hopes of government stimulus calmed investors' fears surrounding the coronavirus and growing signs of imminent recession.
What happened
Oil prices are snapping back today following yesterday's historic sell-off. Crude closed more than 10% higher on the day, fueled in part by a rash of spending cuts across the oil sector.
(RTTNews) - Following the worst day on Wall Street since the 2008 financial crisis, stocks showed wild swings over the course of the trading session on Tuesday before eventually finishing the day sharply higher.
What happened
Shares of JetBlue Airways (NASDAQ: JBLU) climbed nearly 10% on renewed investor confidence that airline stocks can weather a COVID-19 coronavirus-induced travel slump. Many of JetBlue's larger rivals are following that company's lead and bringing down capacity, le
What happened
Shares of Lowe's (NYSE: LOW) were moving higher today as the home-improvement retailer caught a tailwind from the rebound in the broader market on hopes for a federal stimulus. Lowe's also revealed that CEO Marvin Ellison bought about $1 million worth of company
What happened
Shares of Alaska Air Group (NYSE: ALK) climbed nearly 10% on Tuesday afternoon as investors took a second look at airline stocks, which have been beaten down by fears of a travel slump related to COVID-19 outbreaks. The impact on airlines is real, but with shares o
Wall Street roared back to life on Tuesday, rebounding from the brink of bear market confirmation as bargain hunting and hopes of government stimulus calmed investors' looming fears surrounding the coronavirus and growing signs of imminent recession.
With air travel dropping sharply over coronavirus concerns, European carriers like Air France-KLM (OTC: AFLYY) and Delta Air Lines' (NYSE: DAL) joint venture Virgin Atlantic were stuck between a rock and a hard place. So-called "slot rules" at European airports forced them t
Healthcare professionals responding to the COVID-19 outbreak are burning through heaps of face masks and other forms of personal protective equipment. However, since most of the medical protective gear used in the U.S. is manufactured in China, hospital operators have started te
What happened
Shares of cruise operator Carnival (NYSE: CCL) jumped as much as 11.2% in trading Tuesday after President Trump vowed to help the industry. Shares actually hit a 52-week low near midday as well, but at 2:55 p.m. EDT, they were still up 7.2% for the day.
What happened
Shares of Palo Alto Networks (NYSE: PANW) fell 21.4% in February 2020, according to data from S&P Global Market Intelligence. The network security specialist's stock was tracking right alongside the broader market all month long until a mixed second-quarter ear
After a Walmart (NYSE: WMT) employee in Kentucky tested positive for the coronavirus, the retail giant implemented new emergency leave policies to support workers coping with the outbreak.
Novavax (NASDAQ: NVAX), a clinical-stage biotechnology company, is currently perceived as one of the leaders in the race to develop a vaccine for COVID-19. The company recently announced it received a grant of $4 million from the Coalition for Epidemic Preparedness Innovations (